This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price.
William A. Sarraille, JD
Advertisement
William A. Sarraille JD, is Professor of Practice, University of Maryland Francis King Carey School of Law.
ORCID ID: 0009-0008-0593-0473
Articles by William A. Sarraille, JD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders
4
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
5
